Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility

Wang J, Jianhua Wang, Zhou F, FuZhen Zhou, Fu-zhen Zhou, Dong M, Minyue Dong, Ruijin Wu, Wu R, Yuli Qian, Qian Y
Fertility and sterility · 2006 · vol. 85(4) , pp. 1037–1044 · doi:10.1016/j.fertnstert.2005.09.028 · PMID:16580392 · W2098216124
Non-randomised trial OA: closed CC0 ⤵ 19 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Prolonged GnRH agonist therapy reduced endometrial nitric oxide synthase expression in women with endometriosis and infertility.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To determine whether endometrial expression of endothelial nitric oxide synthase (eNOS) or inducible NOS (iNOS) protein in women with endometriosis-associated infertility is different from that in the fertile controls, whether GnRH agonist (GnRH-a) regulates the endometrial expression of NOS in women with endometriosis-associated infertility, and whether there is a correlation between serum E2 or P levels, and the endometrial expression of eNOS or iNOS. DESIGN: Prospective controlled study. SETTING: University hospital for reproductive medicine and gynecologic endocrinology. PATIENT(S): Thirty patients with endometriosis-associated infertility and 19 patients with carcinoma in situ of the cervix. INTERVENTION(S): Endometrial biopsy specimens and blood samples. MAIN OUTCOME MEASURE(S): Endometrial eNOS and iNOS protein relative levels and serum concentrations of E2 or P. RESULT(S): By Western blot analysis, iNOS was not detected, and a unique menstrual cycle-dependent expression of eNOS was observed. Eutopic endometrium in women with endometriosis-associated infertility before GnRH-a treatment showed higher levels of eNOS than that of the control group. After 3 months of GnRH-a therapy, eNOS levels in the endometrium were reduced. In addition, a significant positive correlation was found between serum E2 or P concentrations, and the endometrial expression of eNOS. CONCLUSION(S): The GnRH-a treatment attenuated the endometrial expression of eNOS in women with endometriosis-associated infertility. Endogenous ovarian steroids influence endometrial eNOS expression.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Endometriosis Endometrium Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Infertility, Female Nitric Oxide Synthase Type II Nitric Oxide Synthase Type III Adult Adult Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium Female Female Gene Expression Regulation, Enzymologic Gene Expression Regulation, Enzymologic Gene Expression Regulation, Enzymologic

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (27)

Cited by (19)

Source provenance

europepmc
last seen: 2026-10-09T06:09:53.026058+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:03:44.483075+00:00
unpaywall
last seen: 2026-06-24T06:27:47.060558+00:00
License: CC0 · commercial use OK